|
|
| wheat-OIT / DBV Technologies (0 Trials) |
|
| White-C (filgrastim biosimilar) / Shandong Kexing Bioproducts (0 Trials) |
|
| WI-211094 / WhanIn (0 Trials) |
|
| WIB-801C / WhanIn (0 Trials) |
|
| WIB-901H / WhanIn (0 Trials) |
|
| WIBP Inactivated COVID-19 vaccine (Omicron) / Sinopharm (0 Trials) |
|
| WIBP-CorV / Sinopharm (0 Trials) |
|
| WID-2101 / WhanIn (0 Trials) |
|
| WIE-1902 / WhanIn (0 Trials) |
|
| WIG-1810 / WhanIn (0 Trials) |
|
| WII-2002 / WhanIn (0 Trials) |
|
| Wilate (human factor VIII/von Willebrand factor) / Octapharma (6 Trials) |
|
| Willfact (human von Willebrand factor) / LFB SA (0 Trials) |
|
| WIN-34B / Hamsoa Pharma (0 Trials) |
|
| WIN-902A / WhanIn (0 Trials) |
|
| Winlevi (clascoterone cream 1%) / Cassiopea (6 Trials) |
|
| Winrevair (sotatercept) / BMS, Merck (MSD) (9 Trials) |
|
| WinRho SDF (rho(d) immune globulin (human)) / Kamada (0 Trials) |
|
| WIT-2001 / WhanIn (0 Trials) |
|
| withania somnifera / Oasis (0 Trials) |
|
| WJ01075 / Suzhou Junjing Biomed (0 Trials) |
|
| WJ05129 / Shanghai Junshi Biosci (0 Trials) |
|
| WJ1075 / Wigen Biomedicine, Shanghai Junshi Biosci (0 Trials) |
|
| WM-A1-3389 / WMBIO (0 Trials) |
|
| WM-D2 / WMBIO (0 Trials) |
|
| WM-S1 / WMBIO (0 Trials) |
|
| WN1316 / Wakunaga, Neugen Pharma, Sawai Pharma (0 Trials) |
|
| WNT974 / Novartis (1 Trials) |
|
| WO-12 / Pfizer, Western Oncolytics (0 Trials) |
|
| WO-H1 / Western Oncolytics (0 Trials) |
|
| WO-VET-S3 / Western Oncolytics (0 Trials) |
|
| Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt (0 Trials) |
|
| Wosulin 50/50 (recombinant human insulin biosimilar 50% + isophane insulin biosimilar 50%) / Wockhardt (0 Trials) |
|
| Wosulin N (isophane insulin biosimilar) / Wockhardt (0 Trials) |
|
| Wosulin R (recombinant human insulin biosimilar) / Wockhardt (0 Trials) |
|
| Woulgan (yeast beta-glucan) / ArcticZymes (0 Trials) |
|
| WP-REP1 / Wize Pharma (0 Trials) |
|
| WP1066 / Moleculin, WPD Pharma (0 Trials) |
|
| WP1096 / Moleculin (0 Trials) |
|
| WP1097 / Moleculin (0 Trials) |
|
| WP1122 / Moleculin, CNS Pharma, WPD Pharma (0 Trials) |
|
| WP1220 / WPD Pharma (0 Trials) |
|
| WP1244 / CNS Pharma (0 Trials) |
|
| WP1732 / WPD Pharma (0 Trials) |
|
| WP1874 / CNS Pharma (0 Trials) |
|
| WPD101 / WPD Pharma (0 Trials) |
|
| WRAIR GSK TDEN vaccine / GSK, U.S. Army Medical Research and Development Command (0 Trials) |
|
| WSD0922 / Wayshine Biopharm (0 Trials) |
|
| WSD1227 / Wayshine Biopharm (0 Trials) |
|
| WT1 TCR-transduced T-cell therapy / Takara (0 Trials) |
|
| WT2725 / Sumitomo Pharma (0 Trials) |
|
| WT4869 / Sumitomo Pharma (0 Trials) |
|
| WT501 / Wellstat (0 Trials) |
|
| WTX-124 / Werewolf Therap (0 Trials) |
|
| WTX-330 / Werewolf Therap (0 Trials) |
|
| WTX212 / Westlake Therap (0 Trials) |
|
| WU ALLO CART / Wugen (0 Trials) |
|
| WU CART 002 / Wugen (0 Trials) |
|
| WU CART 007 / Wugen (0 Trials) |
|
| Wu-5 / Shanghai Jiao Tong University (0 Trials) |
|
| WU-NK-101 / Wugen (0 Trials) |
|
| wujia yizhi granules (KH110) / Chengdu Kanghong Pharma (0 Trials) |
|
| WVE-003 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-004 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-005 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-120101 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-120102 / Wave Life Sciences, Takeda (0 Trials) |
|
| WVE-N531 / Wave Life Sciences (0 Trials) |
|
| WVT078 / Novartis (0 Trials) |
|
| WX-037 / Heidelberg Pharma (0 Trials) |
|
| WX-066 / Qilu Pharma (0 Trials) |
|
| WX-554 / Heidelberg Pharma (0 Trials) |
|
| WX-UK1 / RedHill (0 Trials) |
|
| WX008 / Sino Biopharm, WuXi AppTec (0 Trials) |
|
| WX047 / Sino Biopharm, WuXi AppTec (0 Trials) |
|
| WXFL078 / Guangdong Zhongsheng Pharma (0 Trials) |
|
| WXFL10030390 / Guangzhou JOYO Pharma (0 Trials) |
|
| WXFL10203614 / Wuxi Fuxin (0 Trials) |
|
| WXFL1024H251 / Sino Biopharm (0 Trials) |
|
| WXSH0011 / WuXi AppTec (0 Trials) |
|
| WXSH0213 / Guangdong Zhongsheng Pharma (0 Trials) |
|
| WYA-152038 / Ligand, Pfizer (0 Trials) |
|
| WYE-125132 / Pfizer (0 Trials) |
|
| Wynzora (calcipotriene/betamethasone dipropionate) / MC2 Therap, Almirall (0 Trials) |
|
| WZ4002 / Dana-Farber Cancer Institute (0 Trials) |
|
| WZTL-002 / Wellington Zhaotai Therapies (0 Trials) |
|
| X-165 / X-Rx (0 Trials) |
|
| X-339 / Xcovery (0 Trials) |
|
| X-376 / Xcovery (0 Trials) |
|
| X-379 / Xcovery (0 Trials) |
|
| X-414 / Tyrogenex (0 Trials) |
|
| X-480 / Xcovery (0 Trials) |
|
| X-481 / Xcovery (0 Trials) |
|
| X-Synergy / Kangpu Biopharma (0 Trials) |
|
| X071NAB / XBiotech (0 Trials) |
|
| X072NAB / XBiotech (0 Trials) |
|
| X081NAB / XBiotech (0 Trials) |
|
| X4P-002 / X4 Pharma (0 Trials) |
|
| XAB05 / Xenothera (0 Trials) |
|
| Xacrel (ocrelizumab biosimilar) / CinnaGen (0 Trials) |
|
| Xadago (safinamide) / Meiji Seika, Eisai, Valeo Pharma, Zambon, Supernus Pharma (3 Trials) |
|
| Xalkori (crizotinib) / Pfizer (73 Trials) |
|
| xalnesiran (RG6346) / Roche (0 Trials) |
|
| xaluritamig (AMG 509) / Amgen (0 Trials) |
|
| Xanaflu (inactivated influenza vaccine) / Abbott, Viatris (0 Trials) |
|
| Xanaflu Tetra (influenza vaccine (surface antigen, inactivated)) / Viatris (0 Trials) |
|
| Xanamem (UE2343) / Actinogen Medical (2 Trials) |
|
| xanomeline/trospium (KarXT) / BMS (4 Trials) |
|
| Xaprila (xaliproden) / Sanofi (0 Trials) |
|
| XaraColl (bupivacaine) / Innocoll (1 Trials) |
|
| Xartemis XR (oxycodone and acetaminophen CR) / Mallinckrodt (0 Trials) |
|
| Xatmep (methotrexate oral solution) / Azurity Pharma (0 Trials) |
|
| XAV-19 / LFB SA, Xenothera (0 Trials) |
|
| XAV-939 / Novartis (0 Trials) |
|
| XB.2.2 / Cellular Biomedicine (0 Trials) |
|
| XB010 / Exelixis (0 Trials) |
|
| XB014 / Exelixis, Invenra (0 Trials) |
|
| xB3-002 / Bioasis (0 Trials) |
|
| xB3-004 / Bioasis (0 Trials) |
|
| XB628 / Exelixis (0 Trials) |
|
| XC101-D13H / Xoc Pharma (0 Trials) |
|
| XC130 / Xoc Pharma (0 Trials) |
|
| XC221 / RSV Therap (0 Trials) |
|
| XC7 / NP Therap (0 Trials) |
|
| Xcel-hNu / Xcelthera (0 Trials) |
|
| Xcel-hNuP / Xcelthera (0 Trials) |
|
| Xcimzane (certolizumab pegol biosimilar) / Xbrane, Biogen (0 Trials) |
|
| Xcopri (cenobamate) / SK Bio, Angelini Group, Endo (9 Trials) |
|
| XCUR-FXN / Exicure (0 Trials) |
|
| XCUR17 / Exicure (0 Trials) |
|
| Xcytrin (motexafin gadolinum) / AbbVie (2 Trials) |
|
| Xdarzane (daratumumab biosimilar) / Xbrane (0 Trials) |
|
| Xdemvy (lotilaner ophthalmic) / Tarsus Pharma (0 Trials) |
|
| Xdivane (nivolumab biosimilar) / Xbrane (0 Trials) |
|
| Xefo (lornoxicam) / Old API Wind-down, Takeda (4 Trials) |
|
| Xegafri (rociletinib) / Clovis (1 Trials) |
|
| XEL 001HG / Xel Pharma (0 Trials) |
|
| XEL 002BG / Xel Pharma (0 Trials) |
|
| XEL 002BI / Xel Pharma (0 Trials) |
|
| XEL 002LG / Xel Pharma (0 Trials) |
|
| XEL 003FL / Xel Pharma (0 Trials) |
|
| XEL 003FP / Xel Pharma (0 Trials) |
|
| XEL 004FP / Xel Pharma (0 Trials) |
|
| XEL 006LG / Xel Pharma (0 Trials) |
|
| XEL 007DO / Xel Pharma (0 Trials) |
|
| Xeljanz XR (tofacitinib XR) / Pfizer (2 Trials) |
|
| Xelpros (latanoprost ophthalmic emulsion) / Sun Pharma Advanced Research Company (0 Trials) |
|
| Xembify (subcutaneous normal human immunoglobulin 20%) / Grifols (0 Trials) |
|
| Xemys (CD206-targeted liposomal oligopeptide multiple sclerosis vaccine) / Pharmsynthez (0 Trials) |
|
| XEN 103 / Xenon, Novartis (0 Trials) |
|
| XEN D0101 / Xention (0 Trials) |
|
| XEN D0103 / Servier, Xention (0 Trials) |
|
| XEN-101 / Xeno Biosci (0 Trials) |
|
| XEN-801 / Xenon (0 Trials) |
|
| XEN-D0501 / Pila Pharma (0 Trials) |
|
| XEN1101 / Xenon (2 Trials) |
|
| Xen2174 / Xenome (0 Trials) |
|
| XEN393 / Neurocrine (0 Trials) |
|
| XEN701 / Ionis (0 Trials) |
|
| XEN907 / Xenon, Roche (0 Trials) |
|
| Xenical (orlistat) / Roche, GSK (16 Trials) |
|
| Xenleta (lefamulin IV) / Nabriva Therap, Sumitomo Pharma, Er-Kim Pharma (0 Trials) |
|
| Xenleta (lefamulin oral) / Nabriva Therap, Sumitomo Pharma (0 Trials) |
|
| Xenogeneic vaccine / Memorial Sloan-Kettering Cancer Center, Ichor Medical Systems (0 Trials) |
|
| xenomycins (XELRYX3) / Statera BioPharma (0 Trials) |
|
| Xenopax (daclizumab biosimilar) / 3SBio (0 Trials) |
|
| XENP8206 / Xencor (0 Trials) |
|
| XENP9523 / Xencor (0 Trials) |
|
| Xenpozyme (olipudase alfa) / Sanofi (3 Trials) |
|
| xentuzumab (BI-836845) / Boehringer Ingelheim (2 Trials) |
|
| Xeomin (incobotulinumtoxinA) / Merz Pharma (47 Trials) |
|
| Xepi (ozenoxacin) / Maruho, Cipher, Ferrer International (1 Trials) |
|
| Xerava (eravacycline) / SOM Biotech, Ewha Womans University, PAION, Innoviva (1 Trials) |
|
| Xerecept (corticorelin) / Celtic (0 Trials) |
|
| Xermelo (telotristat etiprate) / Ipsen, Lexicon Pharma, TerSera Therap (3 Trials) |
|
| xevinapant (Debio 1143) / EMD Serono (9 Trials) |
|
| Xevudy (sotrovimab) / GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| XF-70 / Destiny Pharma (0 Trials) |
|
| XFB-19 / Xfibra (0 Trials) |
|
| XG-104 / Xigen (0 Trials) |
|
| XH-5102 / Xunhe Pharma (0 Trials) |
|
| Xhance (fluticasone propionate intranasal spray) / OptiNose (0 Trials) |
|
| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo (14 Trials) |
|
| Xiannuoxin (simnotrelvir) / Simcere, Shanghai Inst. of Materia Medica (0 Trials) |
|
| Xience (everolimus-eluting stent) / Abbott (41 Trials) |
|
| Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health (64 Trials) |
|
| Xifaxan EIR (rifaximin extended intestinal release) / Bausch Health, Alfasigma (1 Trials) |
|
| Xiflam (tonabersat) / InflammX (1 Trials) |
|
| Xigduo (dapagliflozin and metformin extended-release) / AstraZeneca (4 Trials) |
|
| Xiidra (lifitegrast) / Bausch Health (6 Trials) |
|
| Ximency (daclatasvir/asunaprevir/beclabuvir) / BMS (0 Trials) |
|
| Ximotini (simotinib) / Simcere, Advenchen (0 Trials) |
|
| Xinhuosu (nesiritide) / China Medical System (0 Trials) |
|
| Xinlay (atrasentan) / Novartis (3 Trials) |
|
| Xinlitan (allisartan) / Allist (12 Trials) |
|
| Xinruibai (pegfilgrastim biosimilar) / Qilu Pharma (0 Trials) |
|
| Xinta (levamlodipine) / Merck (MSD), Simcere (0 Trials) |
|
| Xipere (triamcinolone acetonide) / Clearside Biomedical, Bausch Health, Arctic Vision (1 Trials) |
|
| Xismox XL (isosorbide mononitrate) / Stada (0 Trials) |
|
| Xiyanping / Jiangxi Qingfeng Pharma (0 Trials) |
|
|